Session Tracks

Conference session tracks

The ICID-IS features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Infectious Diseases. Each track gives researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain.

This conference contributes to global sustainability by aligning its research discussions and academic sessions with the United Nations Sustainable Development Goals, fostering knowledge exchange, innovation and collaborative engagement.

SDG 1
SDG 1 No Poverty
SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
SDG 10
SDG 10 Reduced Inequalities
SDG 16
SDG 16 Peace, Justice and Strong Institutions
SDG 17
SDG 17 Partnerships for the Goals
01
Track

Innovative Vaccine Development Approaches

This track focuses on the latest advancements in vaccine research and development, highlighting novel technologies and methodologies. Discussions will encompass mRNA vaccines, viral vector platforms, and other cutting-edge strategies aimed at combating infectious diseases.

02
Track

Public Health Campaigns and Vaccine Uptake

This session will explore effective public health campaigns designed to increase vaccination rates in diverse populations. Emphasis will be placed on communication strategies, community engagement, and addressing vaccine hesitancy.

03
Track

Herd Immunity and Population Health

This track examines the concept of herd immunity and its critical role in controlling infectious disease outbreaks. Participants will discuss mathematical models, thresholds for immunity, and implications for public health policy.

04
Track

Cold Chain Logistics in Vaccine Distribution

This session will delve into the logistical challenges associated with maintaining the cold chain for vaccine storage and distribution. Topics will include innovative solutions, technology integration, and best practices for ensuring vaccine efficacy.

05
Track

Immunization Policies and Global Health Equity

This track addresses the importance of equitable immunization policies in achieving global health goals. Discussions will focus on barriers to access, policy frameworks, and strategies to enhance vaccine distribution in underserved communities.

06
Track

Vaccine Efficacy and Safety Monitoring

This session will cover the methodologies used to assess vaccine efficacy and safety post-licensure. Participants will discuss surveillance systems, data analysis, and the importance of transparency in maintaining public trust.

07
Track

Booster Programs and Long-term Immunity

This track will explore the role of booster vaccinations in sustaining immunity against infectious diseases. Discussions will include optimal timing, dosage, and the impact of waning immunity on public health strategies.

08
Track

Global Vaccination Coverage and Challenges

This session will analyze the current state of global vaccination coverage and the challenges faced in achieving universal immunization. Topics will include geopolitical factors, funding, and the role of international organizations.

09
Track

Immunotherapy in Infectious Disease Management

This track focuses on the emerging role of immunotherapy as a treatment strategy for infectious diseases. Participants will discuss various immunotherapeutic approaches, including monoclonal antibodies and immune checkpoint inhibitors.

10
Track

Outbreak Prevention and Response Strategies

This session will examine effective strategies for preventing and responding to infectious disease outbreaks. Emphasis will be placed on surveillance, rapid response teams, and the integration of technology in outbreak management.

11
Track

Disease Eradication Efforts and Lessons Learned

This track will review historical and contemporary efforts aimed at eradicating infectious diseases. Participants will discuss successful case studies, ongoing challenges, and the implications for future eradication initiatives.